For Physicians
Elevating Cardiac Care: AI-Powered Insights for Definitive Clinical Action.
Benefits
Proven clinical impact
- Superior Patient Outcomes: Associated with a 26% reduced mortality and 4% reduction in hospitalization length compared to conventional remote monitoring¹.
- Clinical Confidence: FDA-cleared AI algorithms² provide accurate, actionable data, significantly reducing "noise" and alert fatigue.
- Predictive Intelligence: Leverage AI to proactively identify high-risk patients, such as those predicted for Heart Failure hospitalization³.
- Time Reclaimed: Spend less time sifting through irrelevant alerts and more time focusing on critical patient management⁴.
Our offering
A unified AI platform
Implicity provides a universal, AI-driven platform that integrates all your CIED data into a single, comprehensive view. Our solution cuts through data volume to deliver only the clinically relevant, high-quality information needed for confident, timely diagnostic and treatment decisions.
Grenoble-Alpes University Hospital (FR)
Universal Platform:
Consolidate data from the 5 major device manufacturers into one interface for seamless clinical review.
Signal HF³:
FDA-cleared algorithm that forecasts the risk of Heart Failure hospitalization.
ILR ECG Analyzer⁵:
Uses AI to reduce false positives by up to 79% in ILR ECG recordings, while maintaining high sensitivity⁶.
AF Alert Management⁷:
Detect clinically relevant events, leading to an 85% decrease in unnecessary Atrial Fibrillation burden alerts⁸.
¹Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024.
²IM007 ILR ECG Analyzer is an FDA cleared Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information. SignalHF is an FDA-cleared Class II medical device, see the instructions for use for more information. SignalHF is not available for sale in Europe.
³SignalHF is an FDA-cleared Class II medical device, see the instructions for use for more information. SignalHF is not available for sale in Europe.
⁴Implicity study conducted in 2023 based on data from 56 medical centers, to measure the increase in productivity of medical teams after two years of using the Implicity platform.
⁵IM007 ILR ECG Analyzer is an FDA cleared Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information.
⁶Rosier, Arnaud, et al., A novel machine learning algorithm has the potential to reduce by 1/3 the quantity of ILR episodes needing review, European Heart Journal, Volume 42, Issue Supplement_1, October 2021.
⁷IM009 AF Alert Management is a CE marked class I medical device (MDD 93/42/EEC), see the instructions for use for more information. Covered under the conditions defined in Article L. 162-52 of the French Social Security Code.
⁸Lazarus, Arnaud, et al. « Filtering of remote monitoring alerts transmitted by cardiac implantable electronic devices and reclassification of atrial fibrillation events by a new algorithm. » Cardiovascular Digital Health Journal 4.5 (2023): 149-154.
“The presentation, the ease of use and the speed of execution make the remote monitoring activity more efficient and pleasant”.